 |
FTI Consulting handles Abcam as the British biotechnology company agrees to a $5.7B takeover from DC-based Danaher Corp., which chalked up $31.5B in fiscal 2022 revenues.
Abcam will operate as a standalone company in Danaher’s life sciences division to bolster its strategy “to help map complex diseases and accelerate the drug discovery process."
Founded in Cambridge in 1998, Abcam’s validated antibodies, reagents, biomarkers and assays are used by an estimated 750K researchers.
Danaher CEO Rainer Blair said Abcam’s long track record of innovation and breadth of antibody portfolio positions makes it a key partner for the scientific community.
The transaction is expected to close mid-2024.
FGS Global represents private equity firm Thoma Bravo as it makes a $4.6B bid for Darktrace, a UK-based cybersecurity artificial intelligence firm.
Edelman handles Viking Holdings, the river and ocean luxury cruise line that plans to raise $1B via an IPO priced in the $21 to $25 per share range.
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.
Have a comment? Send it to 
No comments have been submitted for this story yet.